Moderna (bStocks Tokenized Stock) vs Strategy PP Variable xStock

Strategy PP Variable xStock (STRCX) is 45.5× the size of Moderna (bStocks Tokenized Stock) (MRNAB) by market capitalisation. Over the past 90 days, MRNAB is ahead by 30.8 percentage points (MRNAB +32.4% against STRCX +1.6%). Their daily returns move barely in opposite directions (correlation -0.08 across 58 shared trading days). MRNAB has been the more volatile of the two, at 98% annualised against STRCX's 55%.

Correlation
-0.08
Size ratio
1 : 45.5
Ahead over 90 days
MRNAB
Moderna (bStocks Tokenized Stock)MRNAB

$199.6100

24h
-0.30%
Market cap
$2.22M
Volume 24h
$25.59M
Volatility (ann.)
98%
Strategy PP Variable xStockSTRCX

$99.7100

24h
-3.42%
Market cap
$101.13M
Volume 24h
$681,747
Volatility (ann.)
55%
MRNAB 2.1%Share of the two combined market caps97.9% STRCX

Performance

MRNABSTRCX

  1. 7 days-8.42%-6.29%STRCX
  2. 30 days-18.71%-5.10%STRCX
  3. 90 days+32.40%+1.63%MRNAB

Correlation

-0.08over 58 shared trading days

−1 opposite0 unrelated+1 in step
7d: insufficient data30d: 0.0990d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

MetricMRNABSTRCX
Max drawdown (400d)-27.9%-8.1%
Risk-adjusted return (90d)0.330.03

Relative strength over 90 days: MRNAB outperformed STRCX by 31.8% — measured on the MRNAB/STRCX ratio, so it holds regardless of market direction.